Literature DB >> 25862298

Aggregation and antigenicity of virus like particle in salt solution--A case study with hepatitis B surface antigen.

Yi Chen1, Yan Zhang2, Can Quan3, Jian Luo2, Yanli Yang2, Mengran Yu2, Yingjun Kong2, Guanghui Ma2, Zhiguo Su4.   

Abstract

The phenomenon of aggregation of virus-like particles (VLPs) in salt solution and the corresponding effect upon antigenicity was reported. Asymmetrical flow field-flow fractionation (AF4) combined with multi-angle laser light scattering (MALLS) was used to characterize the size and the aggregation behavior of hepatitis B surface antigen (HBsAg). The average diameter of HBsAg VLP was 22.8±0.4 nm and it tended to aggregate in salt solution to form large particles and the antigenicity changed accordingly. In 0-4 M NaCl solution, part of HBsAg molecules aggregated rapidly into oligomeric particles (OP), whose diameter distributed from 25 to 40 nm, and the antigenicity slightly decreased about 10%. The aggregation reaction is reversible. After removing NaCl, both size and antigenicity could recover to normal level (92-96%). By contrast, the aggregation process is more complicated in (NH4)2SO4 solution. Most of HBsAg particles aggregated into OP and further aggregated into polymeric particles (PP). The diameter of the PP could reach 40 to 140 nm. The concentration of (NH4)2SO4 had remarkable influence upon the rate of aggregation. When concentration of (NH4)2SO4 was below 1 M, most of HBsAg aggregated only into OP in 1 h. While with concentration of (NH4)2SO4 above 1 M, most of particles formed PP within 1 h. The aggregation process to PP was irreversible. After removing (NH4)2SO4, the large aggregates could not recover to normal particles and the remaining antigenicity was below 30%.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aggregation; Antigenicity; Asymmetrical flow field-flow fractionation; Hepatitis B surface antigen; Virus-like particle

Mesh:

Substances:

Year:  2015        PMID: 25862298     DOI: 10.1016/j.vaccine.2015.03.078

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  Biochemical and biophysical characterization of maize-derived HBsAg for the development of an oral vaccine.

Authors:  Shweta Shah; Celine A Hayden; Maria E Fischer; A Gururaj Rao; John A Howard
Journal:  Arch Biochem Biophys       Date:  2015-10-28       Impact factor: 4.013

2.  Halophilic viruses with varying biochemical and biophysical properties are amenable to purification with asymmetrical flow field-flow fractionation.

Authors:  Katri Eskelin; Mirka Lampi; Florian Meier; Evelin Moldenhauer; Dennis H Bamford; Hanna M Oksanen
Journal:  Extremophiles       Date:  2017-10-10       Impact factor: 2.395

3.  Structural Characterization and Physicochemical Stability Profile of a Double Mutant Heat Labile Toxin Protein Based Adjuvant.

Authors:  Vishal M Toprani; John M Hickey; Neha Sahni; Ronald T Toth; George A Robertson; C Russell Middaugh; Sangeeta B Joshi; David B Volkin
Journal:  J Pharm Sci       Date:  2017-08-02       Impact factor: 3.534

4.  3D visualisation of hepatitis B vaccine in the oral delivery vehicle SBA-15.

Authors:  Martin K Rasmussen; Nikolay Kardjilov; Cristiano L P Oliveira; Benjamin Watts; Julie Villanova; Viviane Fongaro Botosso; Osvaldo A Sant'Anna; Marcia C A Fantini; Heloisa N Bordallo
Journal:  Sci Rep       Date:  2019-04-15       Impact factor: 4.379

5.  A method to induce hen egg lysozyme-specific humoral immune tolerance in mice by pre-exposition with the protein's oligomers.

Authors:  Takatoshi Ohkuri; Natsuko Yuge; Kenji Sato; Tadashi Ueda
Journal:  Biochem Biophys Rep       Date:  2019-08-14

Review 6.  Asymmetrical Flow Field-Flow Fractionation on Virus and Virus-Like Particle Applications.

Authors:  Katri Eskelin; Minna M Poranen; Hanna M Oksanen
Journal:  Microorganisms       Date:  2019-11-12

7.  Self-assembly into virus-like particles of the recombinant capsid protein of porcine circovirus type 3 and its application on antibodies detection.

Authors:  Yu Wang; Gang Wang; Wei-Tong Duan; Ming-Xia Sun; Meng-Hang Wang; Shang-Hui Wang; Xue-Hui Cai; Ya-Bin Tu
Journal:  AMB Express       Date:  2020-01-07       Impact factor: 3.298

8.  Cost-effective purification process development for chimeric hepatitis B core (HBc) virus-like particles assisted by molecular dynamic simulation.

Authors:  Bingyang Zhang; Shuang Yin; Yingli Wang; Zhiguo Su; Jingxiu Bi
Journal:  Eng Life Sci       Date:  2021-05-03       Impact factor: 2.678

9.  Stability Studies of the Vaccine Adjuvant U-Omp19.

Authors:  M Laura Darriba; María L Cerutti; Laura Bruno; Juliana Cassataro; Karina A Pasquevich
Journal:  J Pharm Sci       Date:  2020-10-12       Impact factor: 3.534

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.